Hummingbird Bioscience Licenses HMBD-002, Phase II-Ready Anti-VISTA Monoclonal Antibody to Percheron Therapeutics Notified -
Teva to Host Conference Call to Discuss Second Quarter 2025 Financial Results at 8 a.m. ET on July 30, 2025 Notified -
IdentiFlight Partners with Aerovantage to Offer AI-Driven Bird Protection in Chilean Wind Farms Notified -
IBFD Expands Access to Critical Tax Research for over 11,500 Institutions in Low- and Middle-income Countries through New Partnership with Research4Life Notified -
Trident and Democratic Republic of Congo Sign Final Digital Identity Partnership and Launch Nationwide “DRCPass” Deployment Notified -
VCIG’s Consulting Arm, V Capital Consulting Group, Secures IPO Advisory Mandate with Malaysia’s Leading Cloud Tax Platform Notified -